Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Internal Medicine
•
Neurology
•
Vascular Neurology
Would you avoid triptans in patients with CADASIL?
Related Questions
How to approach reversal of TNK in hemorrhagic conversion of ischemic stroke?
How do you manage patients with a prior intracerebral hemorrhage from probable cerebral amyloid angiopathy who develop new small vessel ischemic infarcts?
Is there a role for using parenteral anticoagulation for occlusive extensive ICA thrombus with acute onset of symptoms when patients are not candidates for endovascular therapy, such as low NIHSS?
When do you consider treating intracerebral hemorrhage associated with cerebral amyloid angiopathy as an inflammatory CAA?
How do you counsel patients on wearable heart monitor devices when they ask about specific products and diagnostic accuracy of these devices available on the market?
How do you determine which patients with ICAS are the best candidates for balloon angioplasty versus those who should continue with aggressive medical management alone?
What is your approach to the treatment of idiopathic intracranial hypertension with transverse sinus stenosis?
Do you consider intervention vs medical therapy alone in patients with an ischemic stroke and suspected symptomatic ipsilateral carotid web with less than 50% stenosis?
How would you manage a CVST secondary to a traumatic brain injury with the presence of intracranial hemorrhage?
What is your approach to managing patients who initially present with symptomatic intracranial large vessel occlusion but subsequently experience resolution of symptoms or become non-disabling before any intervention?
